N. Berger-Dutrieux

Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer.

F. Berger, F. Borson‐Chazot, B. Rousset, 2008, The Journal of clinical endocrinology and metabolism.

Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues.

Agnès Perrin, B. Rousset, J. Peix, 2002, The Journal of clinical endocrinology and metabolism.

Thyroid cancer: is the incidence rise abating?

G. Sassolas, F. Borson‐Chazot, J. Orgiazzi, 2009, European journal of endocrinology.

A monoclonal antibody (Bl2‐10D1) reacting with a bladder‐cancer‐associated antigen

R. Bouvier, M. Devonec, G. Escourrou, 1989, International journal of cancer.

Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.

B. Franc, F. Borson‐Chazot, Agnès Perrin, 2004, The American journal of pathology.

Studies of monoclonal antibody bl2‐10d1 as a marker for the detection of the urothelial origin of tumors

A. Cochran, M. Devonec, B. Fontanière, 1993, Cancer.

0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(5):3028–3035 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1394 Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations

F. Borson‐Chazot, B. Rousset, J. Orgiazzi, 2022 .

[112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].

P. Gosset, B. Caillou, A. Duhamel, 1999, Annales de pathologie.

[Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)].

J. Trouillas, N. Berger-Dutrieux, J. Saint-André, 1994, Archives d'anatomie et de cytologie pathologiques.